Norwick B. H. Goodspeed
Keine laufenden Positionen mehr
Profil
Norwick B.H.
Goodspeed has been President and Chief Executive Officer of FlowCardia, Inc. since March 2004 and a Director of MicroMed Cardiovascular, Inc. since March 2003.
Prior to joining FlowCardia, he was President of McGaw, Inc. and President and Chief Executive Officer of Vical, Inc. Mr. Goodspeed was President and Chief Executive Officer of TransVascular, Inc. from May 2000 to January 2004 and Ocular Sciences from June 1997 to May 2000.
Previously, he held various executive positions at BOC Healthcare and Baxter.
Mr. Goodspeed received an MBA degree from Stanford University and a BA from Yale University.
Ehemalige bekannte Positionen von Norwick B. H. Goodspeed
| Unternehmen | Position | Ende |
|---|---|---|
TransVascular, Inc.
 TransVascular, Inc. Medical SpecialtiesHealth Technology Transvascular (TVI) is a development stage medical device company that is definig a new class of intervention for the treatment of vascular diseases and other disorders. Unlike conventional therapies that are limited to treatment within blood vessels, the company's novel therapeutic approach extends beyond the vessel boundaries | Präsident | 01.01.2004 |
Ocular Sciences, Inc.
 Ocular Sciences, Inc. Medical SpecialtiesHealth Technology Ocular Sciences, Inc. was manufacturer and marketer of contact lenses for annual and disposable replacement regimens. It used to manufacture soft contact lenses such as disposable toric, cosmetic, aspheric, multi-focal, sports and extended-wear lenses. Ocular sciences was marketing their products exclusively to eye care practitioners, both in private practice and retail chains. The company was founded in 1983 and was headquartered in Concord, CA. | Vorstandsvorsitzender | 01.05.2000 |
Baxter Corp.
 Baxter Corp. Medical SpecialtiesHealth Technology Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada | Corporate Officer/Principal | - |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Präsident | - |
McGaw, Inc.
 McGaw, Inc. Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, McGaw, Inc. is a marketing technology agency that specializes in helping businesses build the perfect martech stack and setup marketing automation for growth. The company is based in Irvine, CA. McGaw implements and tracks analytics to ensure correct implementation and offers expert help with marketing and sales stack implementation, lead generation, funnel optimization, or email automation. In 1997, McGaw was acquired by B. Braun Melsungen AG from IVAX LLC for $400 million. | Präsident | - |
Ausbildung von Norwick B. H. Goodspeed
| Stanford University | Masters Business Admin |
| Yale University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Health Technology |
MicroMed Cardiovascular, Inc.
 MicroMed Cardiovascular, Inc. Medical SpecialtiesHealth Technology MicroMed Cardiovascular, Inc. is a medical company engaged in the manufacture and distribution of miniaturized heart pump known as the DeBakey VAD to address congestive heart failure. The company was founded on October 6, 1995 is headquartered in Houston, TX. | Health Technology |
McGaw, Inc.
McGaw, Inc. Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, McGaw, Inc. is a marketing technology agency that specializes in helping businesses build the perfect martech stack and setup marketing automation for growth. The company is based in Irvine, CA. McGaw implements and tracks analytics to ensure correct implementation and offers expert help with marketing and sales stack implementation, lead generation, funnel optimization, or email automation. In 1997, McGaw was acquired by B. Braun Melsungen AG from IVAX LLC for $400 million. | Health Technology |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
TransVascular, Inc.
TransVascular, Inc. Medical SpecialtiesHealth Technology Transvascular (TVI) is a development stage medical device company that is definig a new class of intervention for the treatment of vascular diseases and other disorders. Unlike conventional therapies that are limited to treatment within blood vessels, the company's novel therapeutic approach extends beyond the vessel boundaries | Health Technology |
Ocular Sciences, Inc.
Ocular Sciences, Inc. Medical SpecialtiesHealth Technology Ocular Sciences, Inc. was manufacturer and marketer of contact lenses for annual and disposable replacement regimens. It used to manufacture soft contact lenses such as disposable toric, cosmetic, aspheric, multi-focal, sports and extended-wear lenses. Ocular sciences was marketing their products exclusively to eye care practitioners, both in private practice and retail chains. The company was founded in 1983 and was headquartered in Concord, CA. | Health Technology |
Baxter Corp.
Baxter Corp. Medical SpecialtiesHealth Technology Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada | Health Technology |
